COMP <GO>
SMTI vs UNH // GROSS PROFIT MARGIN
Sanara MedTech Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: SMTI 7
— UNH 5
▲ GROSS PROFIT MARGIN LEADER: SMTI
LAST: $32.92 (+0.11%) • MKT CAP: $302.4M
gross-margins
92.70%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMTI | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 92.70% | 88.57% | +4.13 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | 11.47% | +4.83 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.5x | 16.4x | +13.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 0.71% | 6.48% | -5.77 | UNH | /fcf-yield <GO> |
| Operating Margin | 7.10% | 4.82% | +2.28 | SMTI | /operating-margins <GO> |
| Net Profit Margin | 36.40% | 3.14% | +33.26 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | 19.00% | 6.46% | +12.54 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | 3.12 | +0.13 | SMTI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 27.3 | 59.2 | -31.86 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.8x | 17.1x | -10.29 | SMTI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $302.4M | $368.83B | -$368.53B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMTI REV | UNH REV | SMTI GROSS % | UNH GROSS % | SMTI FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $103.1M | $447.57B | 92.7% | 88.7% | $2.2M | $16.07B |
| FY 2024 | $86.7M | $400.28B | 90.6% | 88.3% | -$229.6K | $20.70B |
| FY 2023 | $65.0M | $371.62B | — | 89.6% | -$3.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
UNH // BETA 0.33